Tag: (NASDAQ:ADAP)
September 9, 2019
Adaptimmune Therapeutics Receives Orphan Drug Designation
Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that the US Food and Drug Administration (FDA) has granted it orphan drug designation for...
August 27, 2019
Adaptimmune and Noile-Immune to Develop SPEAR T-Cell Products
The companies anticipate that they will be able to receive approval for first human testing as early as 2021. August 27, 2019
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products
Adaptimmune Therapeutics (NASDAQ:ADAP) has announced that it and Noile-Immune Biotech will co-develop SPEAR T-cell products based on the co-expression of...
December 30, 2018
5 Top Weekly NASDAQ Biotech Stocks: Dova Up 41 Percent
Dova Pharmaceuticals, Sesen Bio, Adaptimmune Therapeutics, Mustang Bio and Equillium were last week's top gainers.
December 17, 2018
Biotech Trends 2018: Immuno-oncology Disappoints
2018 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...
October 22, 2018
8 Top Gains and Losses at 2018’s ESMO Event
Big Pharma players and smaller oncology-focused companies alike were among the presenters at the annual meeting, which runs from October...
October 16, 2018